We have an updated report [Version - 2023] available. Kindly sign up to get the sample of the report.
all report title image
  • Published On : Jan 2022
  • Code : CMI4865
  • Pages : 123
  • Formats :
      Excel and PDF
  • Industry : Medical Devices

A pacemaker is inserted in the chest to help manage the heartbeat of patient. It is used from preventing the heart from beating slowly. It requires surgical procedure to insert a pacemaker in the chest. Pacemaker is also known as cardiac pacing device. The pacemaker starts sending the electrical signals if the heartbeat is slow to correct the beat. The new pacemakers have the sensors which detect the body motion or breathing rate and signals the device to increase the heart rate through the exercise, as per needed. Pacemaker has 2 parts: pulse generator and lead (electrodes). The pacemaker would stop functioning because of some electrical involvement, such as Cell phones, Security systems, medical equipment, and power-generating equipment.

Some pacemakers can also help the chambers of heartbeat in sync. Brazil cardiac pacemakers market would witness a significant growth during the forecast period (2021 - 2028), owing to increasing need of cardiac pacemaker implantation due to high prevalence of Chagas disease and growing trend of medical tourism in Brazil.

Brazil cardiac pacemakers market is estimated to be valued at US$ 305 million in 2021 and is expected to exhibit a CAGR of 2.4% over the forecast period (2021-2028).

Figure 1. Brazil Cardiac Pacemakers Market Value (US$ Mn), By Product Type, 2021

 | Coherent Market Insights

Figure 1.1 Brazil Cardiac Pacemakers Market Value (US$ Mn), By Product Type, 2028

 | Coherent Market Insights

Hydroxychloroquine Market Report Coverage

Report Coverage Details
Base Year: 2020 Market Size in 2021: US$ 305 Mn
Historical Data for: 2017 to 2020 Forecast Period: 2021 to 2028
Forecast Period 2021 to 2028 CAGR: 2.4% 2028 Value Projection: US$ 359.3 Mn
Geographies covered:
  • Brazil
Segments covered:
  • By Product Type: Implantable Cardiac Pacemaker, External Cardiac Pacemaker
  • By Technology: Single Chamber Pacemaker, Dual Chamber Pacemaker, Biventricular Pacemaker
  • By End Users: Hospitals, Cardiac Clinics, Ambulatory Surgery Centers
Companies covered:

BIOTRONIK SE & Co.KG, Medtronic plc., Boston Scientific Corporation, Abbott Laboratories, LivaNova plc., Osypka Medical GmbH, and MEDICO S.p.A.

Growth Drivers:
  • Increasing Need for Adoption of Cardiac Pacemakers
  • Growing Trend of Medical Tourism in Brazil
Restraints & Challenges:
  • Infections Associated with Cardiac Pacemaker Implantation 
  • Combined Efforts of Government and Key Market Players to Increase Patient Access

Figure 2. Brazil Cardiac Pacemakers Market Value (US$ Mn), By Technology, 2021

 | Coherent Market Insights

Figure 2.1 Brazil Cardiac Pacemakers Market Value (US$ Mn), By Technology, 2028

 | Coherent Market Insights

Various government and private organizations are focused on initiatives for increasing awareness regarding Chagas disease, which is expected to increase treatment rate, and adoption rate of cardiac pacemakers in Brazil.

The increasing product launches and approvals are expected to drive the market growth over the forecast period.

For instance, in August 2017, the U.S. FDA assured an alert regarding the security flaws in 465, 000 pacemakers of Abbott Laboratories and recalled them, stating that, these pacemaker may be vulnerable to hacking.

According to U.S. FDA, security flaws allows hackers to reprogram the devices to run the batteries down or modify the patients’ heartbeat, putting millions of patients’ lives at risk.

Brazil Cardiac Pacemakers Market – Impact of Coronavirus (Covid-19) Pandemic

Coronavirus (COVID-19) outbreak was first reported on December 31, 2019, in Wuhan, China. The World Health Organization declared COVID-19 as pandemic on March 11, 2020. According to the Coronavirus (COVID-19) Weekly Epidemiological Update by the World Health Organization, over 3.3 million new cases were reported, across the globe.

The COVID-19 pandemic and lockdown in various countries across the globe has negatively impacted the financial status of businesses across all sectors. The COVID-19 pandemic has impacted the entire supply chain of the healthcare industry mainly due to strict lockdown in several regions. Likewise, COVID-19 pandemic is expected to have a negative impact on Cardiac Pacemakers Market Cardiac Pacemakers Market            

For instance, as per National Library of Medicine, reduction in pacemaker implantation of 73% was noticed within the COVID-19 pandemic period, and reduction of 78% in patients with the treatment of complete atrioventricular block and reduction in de-novo pacemaker insert was noticed.

Brazil Cardiac Pacemakers Market Restraint

Cardiac pacemaker infections are complex to manage, as there are intra-cardiac and extra-cardiac components, which may get infected and removal of the device is associated with a risk of death or significant complications. Long term hospital stays and multiple in-patient hospital admissions are common in pacemaker infections and efforts to treat infected systems often results in unnecessarily prolonged courses of treatment. Furthermore, cardiac pacemaker infections can be difficult to diagnose. The diagnosis is more difficult in infective endocarditis (IE) as echocardiography is less accurate, blood cultures are less sensitive, and the diagnosis is often not considered.

Key Players

Major players operating in the Brazil cardiac pacemakers market include BIOTRONIK SE & Co.KG, Medtronic plc., Boston Scientific Corporation, Abbott Laboratories, Ivanovo plc., Osyka Medical GmbH, MEDICO S.p.A

Frequently Asked Questions

Brazil cardiac pacemakers market size is estimated to be valued at US$ 359.3 million in 2028 and is expected to exhibit a CAGR of 2.4% between 2021 and 2028.

The increasing need for adoption of cardiac pacemakers, growing trend of medical tourism, and combined efforts of government and key market players to increase patient access to service or facilities are the major factors which are expected to drive the market growth over the forecast period. 

Implantable Cardiac Pacemaker segment is expected to hold major market share over the forecast period, which are surgically implanted in the patient’s chest.

Major factors hampering growth of the market include infections Associated with cardiac pacemaker implantation as a treatment for bradyarrhythmias and other cardiac rhythm disorders.

Major players operating in the market include BIOTRONIK SE & Co.KG, Medtronic plc., Boston Scientific Corporation, Abbott Laboratories, LivaNova plc., Osypka Medical GmbH, and MEDICO S.p.A.
  • Need a Custom Report?

    We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

    Customize Now
  • Want to Buy a Report but have a Limited Budget?

    We help clients to procure the report or sections of the report at their budgeted price. Kindly click on the below to avail

    Request Discount

Reliability and Reputation

DUNS Registered
DMCA Protected


Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo